Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Connective Tissue Cell Types

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axis.

Nature communications·2026

Same author

Trust in researchers and willingness to engage in cancer research.

The oncologist·2026

Same author

The Dual Faces of S1P: Orchestrating Immune Responses in Health and Disease.

Cells·2026

Same author

Phase II Trial of Opaganib Addition in Metastatic Castration-Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide.

Cancer medicine·2026

Same author

Taming autoimmunity: Alpha-1 antitrypsin overexpressing mesenchymal stromal cells promote regulatory T cell crosstalk to reverse diabetes.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Same author

Targeting PIM2 improves antitumor immunity through promoting effector function and persistence of CD8 T cells.

The Journal of clinical investigation·2026

Search research articles

Related Experiment Video

Updated: May 14, 2025

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Osteogenesis imperfecta: exploring an autoimmune and immunotherapy perspective.

Jackson F Goddard¹, Shikhar Mehrotra¹, Meenal Mehrotra¹

¹Department of Surgery, Medical University of South Carolina, Charleston, SC 29425, United States.

|May 12, 2025

Summary

Osteogenesis imperfecta (OI), or brittle bone disease, is a genetic disorder lacking FDA-approved treatments. This review highlights evidence suggesting OI has an autoimmune component, potentially paving the way for new immunotherapies.

Keywords:

T cells Treg autoimmunity cytokines immunotherapy inflammation osteogenesis

More Related Videos

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Related Experiment Videos

Last Updated: May 14, 2025

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Area of Science:

Genetics
Immunology
Bone Biology

Background:

Osteogenesis imperfecta (OI), or brittle bone disease, is a genetic disorder affecting type 1 collagen, leading to frequent fractures in young patients.
Despite being known for nearly 200 years, no FDA-approved treatments specifically target the underlying causes of OI, with current therapies focusing only on skeletal defects.

Purpose of the Study:

To review current treatments and clinical trials for Osteogenesis imperfecta.
To analyze OI from an osteoimmunological perspective, exploring potential autoimmune components.
To advocate for the consideration of immunomodulating strategies in OI treatment.

Main Methods:

Literature review of existing treatments and clinical trials for OI.
Analysis of OI through an osteoimmunological lens.
Compilation of evidence supporting an autoimmune component in OI.

Main Results:

Current treatments for OI primarily address skeletal defects, with no FDA-approved disease-modifying therapies.
Evidence suggests a significant, yet often overlooked, autoimmune component in Osteogenesis imperfecta.
Immunology-based therapies have shown preliminary promise in managing OI.

Conclusions:

Recognizing the autoimmune aspect of OI is crucial for understanding its pathogenesis.
Developing novel immunotherapies could lead to more effective treatments for OI.
Rethinking the immune system's role in OI may significantly improve patient quality of life.